I clinical trial currently recruiting participants. Also, this study is being conducted to see if radioimmunotherapy works in treating your multiple myeloma. The patient must have multiple myeloma and have received prior therapy.
Patients can be in relapse or in plateau.
Antibody are not eligible for this study. The treatment will be one cycle. Antibody will be started 4 weeks after your most recent treatment. The treatment lasts approximately 1-2 weeks. Before any injection of radioactivity you will be given one of three medications which are used to prevent build-up of radioactive iodine in your thyroid.